Abstract
Oman, a member of the Arabian Gulf Cooperation Council is a middle-income economy state that has achieved remarkable success in controlling and eradicating major communicable diseases through its sound policies and strategies on the primary health care approach. As observed in other countries in the region, Oman is challenged by the rise in incidence of noncommunicable diseases including cancer. This is a result of the rapid growth and changing age structure of the population together with unhealthy lifestyles. The current economic prosperity of Oman and the sociodemographic changes have led to a shift in the epidemiological patterns of cancer. Delayed presentation of the disease has been attributed to lack of awareness, cultural barriers, and limited screening programs. Understanding these barriers is crucial for optimizing proper cancer prevention. Since 30–50 % of cancers are preventable; therefore, a high priority must be placed on prevention and early detection. In Oman, efforts have been introduced in the last few years to implement health strategies that increase public awareness through community-based programs and education. Ministry of Health along with the national associations is constantly working towards promoting health initiatives in schools and in tobacco control. Oman has achieved a dramatic transformation in cancer care in a remarkably short time. In addition to the existing preventive strategies, stronger measures remain to be accomplished. Furthermore, research is needed to identify the unknown risk factors. Given the country’s extensive experience in health promotion and disease prevention, Oman stands as a model in cancer control for other countries in transition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Health expenditure total (% of GDP): 2010–2014. Oman data.worldbank.org.
Annual report. Central Bank Oman. 2013. www.cbo-oman.org/annual/CBOAnnualReport Accessed Jun 2014.
Country cooperation strategy for WHO and Oman 2010–2015. WHO Document EM/ARD/036/E/12.10. Geneva: WHO.
ESMO designated centers of integrated oncology and palliative care. Lugano: ESMO. http://www.esmo.org/Patients/2014-ESMO-Designated-Centres.
UNDP human development report: sustaining human progress: reducing vulnerabilities and building resilience explanatory note on the 2014 human development report composite indices Oman. http://hdr.undp.org/sites/all/themes/hdr_theme/country-notes/OMN.
Nooyi SC. The Oman national cancer registry—every case counts. Special issue on “non communicable disease surveillance and control”. Newsletter. 2008;17(3):1–7.
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanuem M, Boyle P. International cancer incidence in five continents. IARC Scientific Publications Preventive Chronic Diseases Public Health Research, Practice and Policy #160. Edited by Association of Cancer Registries. Lyon: IARC. ISBN 9789283221609.
Al-Lawati JA, Mabry R, Mohammed AJ. Addressing the threat of chronic diseases in Oman. Prev Chronic Dis. 2008;5(3):A99.
Hajjar R, Atil T, Al-Mandhari Z, Balducci L, Silbermann M. Prevalence of aging population in the Middle East and its implications on cancer incidence and care. Ann Oncol. 2013;24 Suppl 7:vii11–24.
Al-Madouj AN, Eldali A, Al-Zahrani AS. Ten-year cancer incidence report among nationals of the GCC states. 1998–2007 (Cancer Incidence Report of the Cooperation Council States) 2011; Executive Board of Health Ministers’ Council for the Gulf Cooperation Council States, Research Centre Scientific Information Office.
Department of non communicable disease surveillance and control. Trends of cancer 1999–2011, Cancer incidence in Oman. Oman Cancer Registry, Directorate General of Health Affairs, Ministry of Health.
Al-Mahrouqi H, Parkin L, Sharples K. Oman incidence of stomach cancer in Oman and the other gulf cooperation council countries. Oman Med J. 2011;26(4):258–62.
Al-Moundhri M. The need for holistic cancer care framework: breast cancer care as an example. Oman Med J. 2013;28(5):300–1.
Kumar S, Burney IA, Al-Ajmi A, Al-Moundhri MS. Changing trends of breast cancer survival in Sultanate of Oman. J Oncol. 2011;2011:316243.
Mehdi I, Monem EA, Al Bahrani BJ, Al Kharusi S, Nada AM, Al Lawati J, Al LN. Age at diagnosis of female breast cancer in Oman: issues and implications. South Asian J Cancer. 2014;3(2):101–6.
Franseschi S, Wild CP. Meeting the global demands of epidemiologic transition—the indispensable role of cancer prevention. Mol Oncol. 2013;7(1):1–13.
Health facts. Department of Health Information and Statistics, Directorate General of Planning; Ministry of Health. 2013.
imPACT: assessing cancer burden: Sultanate of Oman faces the growing cancer burden report by World Health Organization (WHO), International Agency for Research on Cancer (IARC) and other partner organizations. 2013.
Sharma K, Costas A, Shulman LN, Meara JG. A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol. 2012;2012:121873.
Al-Sharbatti SS, Shaikh RB, Elsheba M, Al-Biate MA. Assessment of breast cancer awareness among female university students in Ajman, United Arab Emirates. Sultan Qaboos Univ Med J. 2014;14(4):493–500.
Brown R, Kerr K, Haoudi A, Darzi A. Tackling cancer burden in the Middle East: Qatar as an example. Lancet Oncol. 2012;13(11):501–8.
Abukhader MM. Thymoquinone in the clinical treatment of cancer: fact or fiction? Pharmacogn Rev. 2013;7(14):117–20. Department of Pharmacy, Oman Medical College, Muscat, Sultanate of Oman.
Oman researchers find cancer treatment in frankincense—Gulf News. http://gulfnews.com/news/gulf/oman/oman-researchers-find-cancer-treatment-in-frankincense-1. Accessed 6 Nov 2013.
Aggarwal A, Sullivan R. Achieving value in cancer care—the case of low- and middle-income countries. http://www.ajmc.com/publications/evidence-based-oncology/2014/the-american-society-of-clinical-oncology-annual-meeting-2014#sthash.XpnLrvsE.dpuf.
WHO. Global action plan for the prevention and control of non-communicable diseases 2013–2020. Geneva: WHO. ISBN 9789241506236.
Wild CP. Cancer control: a reminder of the need for a balanced approach between prevention and treatment. East Mediterr Health J. 2014;20(6):340–62.
Al Dhawi AA, West Jr DJ, Spinelli RJ, Gompf TA. The challenge of sustaining health care in Oman. Health Care Manag (Frederick). 2007;26(1):19–30.
Al-Mulla NA, Chandra P, Khattab M, Madanat F, Vossough P, Torfa E, Al-Lamki Z, Zain G, Muwakkit S, Mahmoud S, Al-Jassmi A, Tuncer M, Al-Mukharraq H, Barsaoui S, Arceci RJ, Howard SC, Kulozik AE, Ravindranath Y, Reaman GH, Farranoush M, AlNasser AA. Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA). Pediatr Blood Cancer. 2014;61(8):1403–10.
Silbermann M, Epner DE, Charalambous H, Baider L, Puchalski CM, Balducci L, et al. Promoting new approaches for cancer care in the Middle East. Ann Oncol. 2013;24 Suppl 7:vii5–vii10.
WHO regional office for the Eastern Mediterranean. Scaling up non communicable disease prevention and control in Oman. 2012. http://www.emro.who.int/media/news/scaling-ncd-oman.html.
Al-Riyami A. Health vision 2050 Oman: a committed step towards reforms. Oman Med J. 2012;27(3):190–1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Al Lamki, Z.M.N. (2016). Cancer Care in Regions/Societies in Transition in the Gulf States: Sultanate of Oman. In: Silbermann, M. (eds) Cancer Care in Countries and Societies in Transition. Springer, Cham. https://doi.org/10.1007/978-3-319-22912-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-22912-6_21
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22911-9
Online ISBN: 978-3-319-22912-6
eBook Packages: MedicineMedicine (R0)